N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
CAS-Nr.
726169-73-9
Englisch Name:
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
Synonyma:
Mocetinostat;MGCD0103;MG0103;CS-1929;Mocetinostat, >=98%;CD0103) Mocetinostat;MGCD0103(Mocetinostat);Mocetinostat (MGCD0103);Mocetinostat, 10 mM in DMSO;Mocetinostat (MGCD0103,MG0103)
CBNumber:
CB42484945
Summenformel:
C23H20N6O
Molgewicht:
396.44
MOL-Datei:
726169-73-9.mol
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Eigenschaften
Schmelzpunkt:
>170oC (dec.)
Dichte
1.340±0.06 g/cm3(Predicted)
storage temp.
RT
L?slichkeit
Soluble in DMSO (up to 25 mg/ml)
pka
13.13±0.70(Predicted)
Aggregatzustand
solid
Farbe
Off-white
Stabilit?t:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
InChI
InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
InChIKey
HRNLUBSXIHFDHP-UHFFFAOYSA-N
SMILES
C(NC1=CC=CC=C1N)(=O)C1=CC=C(CNC2=NC=CC(C3=CC=CN=C3)=N2)C=C1
Sicherheit
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Mocetinostat is a multi-targeted histone deacetylase inhibitor used in cancer therapy. Mocetinostat is undergoing clinical trials for the treatment of various cancers including follicular lymphoma, Hodgkin’s lymphoma and acute myelogenous leukemia.
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 187)Lieferanten
Canada 1
China 161
India 1
United Kingdom 2
United States 22
Global 187
726169-73-9()Verwandte Suche:
MGCD0103(Mocetinostat)
MG0103
Mocetinostat (MGCD0103,MG0103)
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide
Mocetinostat (MGCD0103)
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide Mocetinostat (MGCD0103)
Mocetinostat, >=98%
N-(2-Aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide
MGCD0103;MGCD 0103;MGCD-0103;MG0103
MGCD0103; MGCD 0103; MGCD-0103
CS-1929
Benzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide USP/EP/BP
Mocetinostat
MGCD0103
Mocetinostat, 10 mM in DMSO
CD0103) Mocetinostat
726169-73-9
C23H20ON6
Inhibitor
Inhibitors
API